Medical Device News Magazine

NSF TraQtion Powers Novozymes’ Raw Material Management in Industry First

Novozymes has successfully implemented NSF TraQtion for managing raw material quality and continuously improve compliance for the production of enzymes and proteins across several industries

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

NSF, a leading global public health and safety organization, is pleased to announce that Novozymes, a leader in biosolutions, has become the world’s first company to implement NSF TraQtion software for managing the quality and compliance of raw materials used in the production of enzymes and proteins serving multiple industries.

NSF TraQtion is a cloud-based quality and compliance software that provides organizations with a comprehensive platform to proactively manage their supply chain, sites, and product quality. NSF TraQtion was initially developed to help customers maintain a higher level of food safety and quality compliance. Its implementation by Novozymes demonstrates the versatility of the software across diverse industries, offering timely and insightful information for making informed decisions.

As an industry pioneer in risk management and mitigation solutions, NSF has a proven track record of ensuring product safety, quality, and compliance across various sectors, including food and health science. In today’s increasingly complex supply chains, risks stemming from globalization, extreme weather events, geopolitical influences, and persistent raw material inflation highlight the need for more robust supply chain management solutions.

Matthew Allen, Senior Director, Food & Sustainability Advisory Solutions at NSF……

“We are delighted to have Novozymes as a client utilizing NSF TraQtion. This achievement showcases the versatility and effectiveness of NSF TraQtion digital solutions across diverse industries. With our extensive expertise and deep understanding of global supply chain dynamics, we are confident in our ability to support Novozymes in enhancing their raw material management process.”

Novozymes is also exploring applications of NSF TraQtion within dietary supplements and health sciences in the future, marking the start of NSF TraQtion’s expansion into these sectors.

NSF TraQtion software offers comprehensive data management and business intelligence capabilities. It combines decades of industry expertise with real-time digital insights in a trusted, cloud-based solution that provides businesses with the assurance they need to confidently manage complex and critical data – including supplier compliance, regulatory requirements, and environmental reporting.

“The adoption of NSF TraQtion by Novozymes underscores NSF’s commitment to delivering cutting-edge solutions to address emerging challenges across industries. By harnessing advanced technologies and industry expertise, NSF TraQtion empowers organizations to proactively manage risk, ensure compliance and product quality, and fortify the overall resilience of their supply chains in a single, secure platform,” stated David Lonza, Vice President, Health Sciences, NSF.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”